Synthesis and antimicrobial activity of novel 1,3-oxazolidine nucleoside analogues by Sriharsha, S. N. & Shashikanth, S.
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF NOVEL 1,3-OXAZOLIDINE 
NUCLEOSIDE ANALOGUES 
S.N. Sriharsha and Sheena Shashikanth* 
Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysore - 570 006, India 
e-mail : skanthl@ rediffmail.com 
Abstract : The synthesis of novel 1,3-oxazolidine pyrimidine nucleoside analogues are described. These 
analogues are all derived from the key stereochemically defined intermediate N-tert-butoxy-carbonyl-2-
hydroxymethyl-l,3-oxazolidine-4-ol which was accessible in 57% yield starting from L-serine 
methylester hydrochloride. The heterocyclic bases eg; uracil, thymine etc are efficiently introduced onto 
the 1,3-oxazolidine by the Vorbruggen procedures. The antimicrobial activity of novel 1,3-oxazolidine 
nucleoside analogues are highlighted. The compounds 7d and 7e showed significant activity against 
bacteria and fungus. 
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Introduction 
The potent activity displayed by 3'- azido-3'-deoxythymidine (AZT) against human immunodifficiency 
virus 1 (HIV) provides impetus for the development for the novel nucleoside analogues.2 Unfortunately, 
those compounds with the natural stereochemistry possess undesirable pharmacological properties and are 
susceptible to the development of resistant strains of HIV. In an attempt to overcome some of these 
detrimental side effects, the carbohydrate moiety of 2', 3'-dideoxy nucleoside analogues has been replaced 
by other five membered rings.3 It has been demonstrated that hetero substitution of these rings has a 
profound effect on the biological activity of the resultant nucleoside analogues as displayed by (-)-2'-
deoxy-3'-thiacytidine (3 TC).4 Antiviral nucleoside analogs containing more than one heteroatom in the 
sugar ring have received much attention because of their potent anti-HIV and anti-HBV activities. At 
present, ß-L-(-)-2'-deoxy-3'-thiacytidine (Lamivudine) is clinically used for treatment of AIDS and AIDS-
complex. Interestingly, this compound showed much lower cytotoxicity than its antipode the D-
enantiomer although both are almost equipotent against the replication of HIV-1 and -2 in vitro. 
Oxazolidinones are the new class of antimicrobial agents with activity against broad spectrum of gram 
positive pathogens including staphalococci, streptococci and enterococci.5"7 The oxazolidinone structure 
is relatively simple and allows for diverse synthetic modification. Because of this and because of the 
importance of oxazolidinones as antimicrobial agents, we have efficiently introduced the heterocyclic 
bases eg; uracil, thymine etc onto the 1,3-oxazolidine by the Vorbruggen procedures8 and reported the 
antimicrobial activity of these compounds. 
Our synthetic strategy was based on the preparation of N-tert-butoxycarbonyl-l,3-oxazolidine-4-one (2) 
followed by the reduction and acylation to give 4-acyloxy-1,3-oxazolidine. Thus compound 2 has been 
prepared by condensing di-tert-butyl-di-carbonate with L-serine methyl ester hydrochloride(l) in the 
presence of dimethylaminopyridine (DMAP) and triethylamine.9 The lactam and the ester functional 
groups present has been reduced by using Li(et)3BH at -78° C to get the desired N-tert-butoxycarbonyl-2-
hydroxymethyl-l,3-oxazolidine-4-ol(3)in quantitative yield.10"12 Protection of primary alcoholic group 
using trityl chloride has been carried out in the presence of pyridine to give trityl derivative (4). This was 
subjected to acetylation in the presence of acetic anhydride, dimethylaminopyridine and triethylamine to 
give N-tert-butoxycarbonyl-2-hydroxymethyl- 4-acyloxy-l,3-Oxazolidine (5)13 (Scheme-1) 
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Scheme-1 
The Compound 5 is suitable for coupling with silylated pyrimidine bases under refluxing conditions in 
CH2CN and in the presence Stannic Chloride as lewis acid (Scheme-2). This gave the desired nucleoside 
analogues as an anomeric mixture in moderate yields.14"15. The 'H NMR spectra of the nucleoside 
analogues (7a-f) showed multiplet due to the aromatic protons in the region 6.55-8.10. The signals due to 
the NH protons were appeared in the region at 10.0 and the C'-H proton of the oxazolidine moiety caused 
a singlet in the region 5.05 indicating the attachment of the oxazolidine moiety and the formation of 
configuration. While singlet due to the OH protons in these compounds was noticed at 2.0. The N-tert-
butoxycarbonyl (BOC) and trityl (T) groups are deprotected by stirring it with trifluoroacetic acid at room 
temperature. The structures of the synthesized compounds have been characterized by the spectroscopic 
data and elemental analysis. The results are summarized in Table-1. 
i) Silylated pyrimidine base, TMSOTf or SnCl ,CH CN.O C i i ) TriflouroAcetic acid, RT. 
Base= a)R=H Uracil, b) R=CH Thymine, c) R=SH, -ThioUracil, d) R=F -Flourouracil, 
e) R=Br -BromoUracil, f) R=C1 -ChloroUracil etc 
Scheme-2 
Antimicrobial Activity 
All the synthesized nucleosides were screened for their antimicrobial activity against bacteria E.coli 
(gram negative), S. aureus (gram positive) and fungi viz A. niger, C.albicans and A.flavus, at the conc of 
100 μg/ml, using Norfloxacin and Griseofulvin respectively as reference compounds. These 
investigations have been performed by disc diffusion method by Verma et al.16 The test compounds were 
dissolved in dimethyl formamide and different aliquots were placed in each cup. Incubation was carried 
out at 37° C for 24 hr. The results are summarized in table-2. 
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Table-1: Analytial and spectral data 
Heterocyclic Communications 
Compd. 
No 
Yield 
(%) 
m.p in 
°C 
C,H,N Analysis 
Anal Calcd for 
IR (nujol) cm'1 'HNMR(CDClj ) 
2 60 68 CIOHUNOS, 
C,48.98; H,6.17;N,5.71, 
Found; C48.95;H,6.15;N,5.70 
1710-1720 cm'1 (C=0 of BOC-ester 
group), 
1820 cm'1 ( C O group), 
1690 cm'1 ( C O group). 
4.99(lH,dd), 
3.84 (3H,s), 
3.64 (lH,dd), 3.32 (lH,dd), 
1.51,(9Hs,Boc ester). 
3 57 79 CGHPNOJ.. 
C,49.31;H,7.76;N, 6.39, 
Found; C, 49.29; H, 7.74; N; 6.36. 
1710-1720 cm'1 ( C O of BOC-ester 
group), 3200-3220 cm'1 (OH) 
4.99 (lH,dd), 
3.64 (2H, dd), 1.51,( 9H s , C O ) 2.78 
(d,2H)6.68 (IH, s, CH) , 
2 (2H, s,OH), 
4 65 112 C2.HJ.NO, 
C,72.86;H,6.77; N.3.03, 
Found;72.85;H,6.75; N.3.04. 
1710-1720 cm'1 ( C O of BOC-ester 
group), 3200-3220 cm'1 (OH) 
750 cm'1 (ArH). 
4.99 (lH,dd), 
3.64(1 H,dd), 
1.51,( 9H s, Boc ester ),2.78 (d,2H) 
6.68 (IH, s ,CH) , 
2 (2H, s,OH), 
7.19(15H, s, ArH). 
5 53 130 CMHUNO6 
C,72.55;H,6.61;N,2.78, Found; 72.56; 
H.6.62; N.2.79. 
1710-1720 cm'1 ( O O of BOC-ester goup), 
1690 ( O O of acetoxy gp) 750 on'1 (Ar Η) 
4.99 (lH,dd), 
3.64 (lH.dd), 2.01 (3H,s)2.78 (d,2H) 
1.51,(9H,s,Boc ester 
6.68 (IH, s, CH) , 
2 (2H, s,OH), 
7.1(15H, s, ArH). 
7a 50 C s H „ N , O 4 . 
C,45.07;H,5.16;N,19.71, 
Found;C,45.03;H,5.12; N, 19.70. 
1890 cm'1 (C=0), 
1690 cm' ' (C=0 ), 
2950cm'1 (NH), 
3557 cm'1 (OH) 
10.0(1 H,s,NH), 5.05(1 H,t CH), 
4.05 (2H,t,H2), 
3.84 (2H,t, H2), 
2 .0 ( lH , s , OH) , 
2.3 (IH, s, NH), 
5.76(lH,d,CH), 7.79 ( IH, d, CH); 
7b 45 C ,H„N 3 0 4 , 
C,42.02; H.4.28; 
N,16.34,S,12.45, 
Found;C,42.05;H,4.26;N,16.30, S, 
12.40. 
1890 cm'1 ( C O ) , 
1690 cm ' ( C O ), 
2950 cm-'(NH), 
3557 cm'1 (OH) 
10.0(lH,s,NH), 
5.05(1 H,t, CH), 
4.05 (2H,t,H2), 
3.84 (lH,t, H2), 
2.0 (IH, s, OH), 
2.3 (lH,s,NH), 
I.93(3H,d,CHj) 
7.57 ( IH, s, CH) 
7c 52 C„H„N,04S, 
C,42.02;H,4.28;, 16.34,S, 12.45, 
Found;C,42.05;H,4.26;N, 16.30, S, 
12.40 
1890 cm'1 ( C O ) , 
1690cm"1(CO), 2950cm'1 (NH), 
3557 cm'1 (OH), 
2600 cm'1 (SH) 
10.0(lH,s,NH), 
1.5 (lH,d,SH) 
5.05(lH,t,CH), 4.05(2H,t,H2), 
3.90 (lH,t,H2), 
3.84 (2H,d,H2), 
2.0 (IH, s, OH), 
2.3 (lH,s,NH), 
4.5 (IH, d, IH) 
7.3 ( IH, d, CH) 
7d 48 CJHioFNJO«. 
C,40.16;H,4.18; N,17.57,F,11.29 
Found;C,40.17; H.4.17; 
N, 17.50, F, 11.27 
1890 cm'1 ( C O ) , 
1690 c m ' ' ( C O ) , 
2950 cm'1 (NH), 
3557 cm'1 (OH) 
10.0(lH,s,NH), 
5.05(1 H,t, CH), 
4.06 (2H,t,H2), 
3.90 (lH,t, H2), 
3.84 (2H,d, H2), 
2.0 (IH, s, OH ), 
2.3 (lH,s,NH), 
7.39 ( IH, s, CH) 
7e 51 C,H,0BrN,O<. 
C,32.87; H.3.42; 
N,14.38;Br;27.39 
Found;C,32.85;H,3.32; 
N,14.30;Br;27.38. 
1890 cm'1 ( C O ) , 
1690 c m ' ( C O ) , 
2950 cm"'(NH), 
3557 cm'1 (OH) 
10.0 (lH,s,NH), 
5.05(1H, t,CH), 
4.06 (2H,t,H2), 
3.90 (lH,t, H2), 
2.0 (IH, s, OH ), 
2.3 (lH,s,NH), 
8.24 (lH,s,CH) 
7f 62 C,H,0CIN,O4, 
C,38.70;H,4.03;N,16.93;C1,14.51 
Found;C,38.73;H,4.05;N,6.90;Cl,14.5 
1890 cm'1 ( C O ) , 
1690 cm ' ( C O ) , 
2950 cm'1 (NH), 
3557 cm'1 (OH) 
10.0(lH,s,NH), 
5.05(lH,t, CH), 
4.06 (2H,t,H2), 
3.84 (IH, t, H2), 
2.0 (IH, s, OH) , 
2.3 (lH,s,NH), 
8.24 ( IH, s, CH) 
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Table-2: Effect of compounds 7a-f on bacterial and fungal activity ( Dilution: 10(^g/ml.) 
Compounds 
Antibacterial activity Antifungal activity 
Zone of Inhibition(mm) Zone of Inhibition (mm) 
E.Coli S.Aureus A.niger C.albicans A.flavus 
7a 23 24 24 22 23 
7b 25 24 25 24 26 
7c 25 26 26 27 27 
7d 34 30 31 30 31 
7e 32 30 30 30 31 
7f 30 29 28 30 29 
Norfloxacin 35 32 
Griseofulvin 32 32 32 
Experimental 
The melting points were determined in open capillary and are uncorrected. The IR spectra were recorded 
on Shimatzu FT-IR spectrophotometer in nujol.'H NMR spectra was recorded on Hitatchi R-600 
spectrometer with TMS as internal standard. 
1 N-tert-butoxycarbonyl-4-(methoxy carbonyl)-l,3-oxazolidin-2-one (2) 
Di-tert-butyl-di-carbonate (3 equiv) was dissolved in 4ml of MeCN (or toluene) and placed in an ice bath 
and 0.5 equiv of DMAP and 3 equiv of triethylamine were added. After 5 minutes Serine methyl ester 
hydrochloride (0.083g,0.5 mmol) was added in portions for during 2 mins and the reaction was allowed to 
run for 1 hour more. At the end of the reaction chloroform was added and the solution was washed with 
5% HCl (2x20 ml), dried with MgS04 and evaporated to give the compound 2 as a white solid in good 
yield. 
2 N-tert-butoxycarbonyl-4-(hydroxyl methyl)-l,3-oxazolidin-2-ol (3) 
Compound 2 was dissolved in THF (20ml), cooled to -78° C was added 3 eq of 1M solution of Li(et)3BH. 
The reaction requires 10 to 60 mins for completion. Excess of reagent was destroyed by the addition of 
saturated solution of NH4C1 at -78° C and the reaction mixture was extracted with dichloromethane 
(3x15ml) and dried over anhydrous MgS04 and evaporated to dryness followed by the purification by 
flash chromatography (hexane-ethyl acetate 7:2) afford the compound 3 as light yellow oil. 
3 N-tert-butoxycarbonyl-4-(trityloxy methyI)-l,3-oxazolidine-2-ol (4) 
Compound 3 (0.8979g, 4mmol) and trityl chloride (triphenylmethylchloride) (1.4g,5mmol) were 
dissolved in 20 ml of pyridine and the mixture was heated at 100° C (steam bath) with swirling for 30 
mins. The reaction mixture was cooled at room temperature and then poured in to 100 ml of ice water. 
The slurry was stirred vigorously during quenching. The solid was filtered and washed thoroughly with 
water until it is free from pyridine. Dry the solid separately. Finally recrystallization from acetone-toluene 
to give a white solid of O-trityl derivative. 
4 N-tert-butoxycarbonyl-2-hydroxymethyl- 4-acyloxy-l,3-oxazolidine (5). 
A solution of trityl derivative 4 in CH2C12 was treated with acetic anhydride (2.6gm,26.3 mmol), 
Triethylamine (2.6gm,26.3 mmol) and a catalytic amount of 4-DMAP at room temperature for 3 hrs. The 
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resultant mixture was washed with 5% HCl (3x15ml) and extracted with CH2CI2 (3x20ml) and evaporated 
to dryness and purified by silica gel column chromatography with 5% chloroform: Ethyl acetate 7:2 to get 
white solid. 
5 General procedure for the synthesis of 1,3-oxazolidine nucleoside analogues (7a-f) 
A mixture of pyrimidine base (2.35 mmol) in Hexamethyldisilazane (10 ml) and CH3CN was heated 
under reflux for 5 hrs. After removal of solvent by vacuum pump, a solution of compound 5 (0.786 
mmol) in 15 ml of CH3CN was added to the reaction flask containing the silylated pyrimidine bases and 
then Stannic Chloride (1.4 mmol) was added dropwise at room temperature. After 16 hrs the reaction was 
quenched with 1 ml of saturated NaHC03 and the resultant mixture was concentrated. The crude mixture 
was exctracted with CH2C12 (3x20ml) , washed with aq. NaHC03, dried over MgS04j filterd and 
concentrated. The crude product was purified by silica gel column chromatography with ethyl 
acetate:hexane (7:2) to give nucleoside analogues (6a-f) as yellow oil. Finally BOC and trityl groups were 
deprotected by stirring it with triflouroacetic acid at room temperature afford 7a-f in moderate yield. 
Conclusions 
In conclusion, we have presented short and efficient preparations of the 1,3-oxazolidine nucleoside 
analogues which as a consequence of their low toxicity should prove to be important antimicrobial agents. 
The novel 1,3-oxazolidine nucleoside analogues have been synthesized using Vorbruggen procedure by 
condensing silylated pyrimidine bases with the acylated 1,3-oxazolidine moiety in the presence of lewis 
acid to get the desired products in the moderate yield. The antimicrobial activity of these compounds have 
been studied and in that compounds 7d and 7e with fluoro and bromo substituents showed significant 
activity against E.coli, S.aureus, A. niger, C.albicans and A.flavus among the six compounds screened. 
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